ASTRAZENECA PLC (AZN)
Clinical trial NCT07221253 updates: 1. completion date: 2029-07-04 → 2029-07-31 2. primary completion date: 2029-07-04 → 2029-07-31
Clinical trial NCT07221253 updates: 1. completion date: 2029-07-04 → 2029-07-31 2. primary completion date: 2029-07-04 → 2029-07-31
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical